Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debasis Ghosh

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Langmuir : the ACS Journal of Surfaces and Colloids|December 14, 2022
Developing High-Performance In-Plane Flexible Aqueous Zinc-Ion Batteries with Laser-Scribed Carbon-Supported All Electrodeposited ElectrodesPrahlada Thippeswamy, Pooja B Naik, Hemanth Kumar Beere, et al.
The Oncologist|December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemiaFiroozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summaryPaul G Kluetz, Yang-Min Ning, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summaryYangmin M Ning, William Pierce, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summaryKatherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
The AAPS Journal|November 7, 2023
Drug Dissolution in Oral Drug Absorption: Workshop ReportKimberly Raines, Payal Agarwal, Patrick Augustijns, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Langmuir : the ACS Journal of Surfaces and Colloids|December 14, 2022
Developing High-Performance In-Plane Flexible Aqueous Zinc-Ion Batteries with Laser-Scribed Carbon-Supported All Electrodeposited ElectrodesPrahlada Thippeswamy, Pooja B Naik, Hemanth Kumar Beere, et al.
The Oncologist|December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemiaFiroozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summaryPaul G Kluetz, Yang-Min Ning, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summaryYangmin M Ning, William Pierce, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summaryKatherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
The AAPS Journal|November 7, 2023
Drug Dissolution in Oral Drug Absorption: Workshop ReportKimberly Raines, Payal Agarwal, Patrick Augustijns, et al.
Pageof 5